Please login to the form below

Translate Bio

This page shows the latest Translate Bio news and features for those working in and with pharma, biotech and healthcare.

In addition to the GSK partnership, Sanofi also signed an agreement with Translate Bio to develop an mRNA-based COVID-19 vaccine.

Sanofi and Translate Bio eye launch of phase 1/2 COVID-19 vaccine study

Preclinical data for mRNA-based vaccine supports clinical development. Sanofi and Translate Bio’s mRNA-based COVID-19 vaccine induced high antibody levels in preclinical studies, leading to the production of ... According to Sanofi and Translate Bio,
Translate Bio, Sanofi's COVID-19 vaccine proves promising in animal studies

Vaccine was able to induce neutralising antibodies and T-cell responses. Translate Bio has announced that its Sanofi-partnered experimental COVID-19 vaccine induced immune responses in animal studies, as they ... We are excited by the novel technology
Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK

The other candidate, which Sanofi is developing with Translate Bio, leverages mRNA technology against the novel coronavirus disease.

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

COVID-19: the race to find a vaccine

BioNTech, CureVac and Translate Bio are also working on mRNA vaccines, while Pfizer and Sanofi are involved in those programmes through partnerships with BioNTech and Translate Bio, respectively.
Developing a COVID-19 vaccine

The second agreement, with Translate Bio, will focus on developing an mRNA vaccine for COVID-19. ... Translate has already begun to produce multiple mRNA constructs and will use its platform to discover, design and manufacture a number of coronavirus

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Ann Barbier joins Translate Bio as its chief medical officer

US-based biotech Translate Bio has appointed Ann Barbier as its new chief medical officer. ... She said: “With near-term clinical programmes in cystic fibrosis and OTC deficiency, Translate Bio is approaching a critical and exciting time.
US biotech Translate Bio appoints Daniella Beckman

She joins the board of directors. Translate Bio has appointed Daniella Beckman to its board of directors and she will also serve at the US biotech as chairperson of its ... Ronald Renaud, chief executive officer, Translate Bio, said: “Daniella joins

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Commercial Finance Director, Healthcare Marketing Communications...: up to £90K

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Add my company

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

An EU emergency health fund to limit the impact of future crises: Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective: The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease: Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...